JPS62277322A - 安定化された腸溶性抗潰瘍固形組成物 - Google Patents
安定化された腸溶性抗潰瘍固形組成物Info
- Publication number
- JPS62277322A JPS62277322A JP2999787A JP2999787A JPS62277322A JP S62277322 A JPS62277322 A JP S62277322A JP 2999787 A JP2999787 A JP 2999787A JP 2999787 A JP2999787 A JP 2999787A JP S62277322 A JPS62277322 A JP S62277322A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- alkyl
- magnesium
- formula
- examples
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2956786 | 1986-02-13 | ||
| JP61-29567 | 1986-02-13 | ||
| JP61-38059 | 1986-02-21 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2316379A Division JPH0825905B2 (ja) | 1990-11-20 | 1990-11-20 | 医薬固形組成物用安定化剤および安定化方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62277322A true JPS62277322A (ja) | 1987-12-02 |
| JPH0338247B2 JPH0338247B2 (fr) | 1991-06-10 |
Family
ID=12279703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2999787A Granted JPS62277322A (ja) | 1986-02-13 | 1987-02-12 | 安定化された腸溶性抗潰瘍固形組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS62277322A (fr) |
Cited By (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62258320A (ja) * | 1986-04-30 | 1987-11-10 | Yoshitomi Pharmaceut Ind Ltd | 内服用新規医薬製剤 |
| JPS62258316A (ja) * | 1986-04-30 | 1987-11-10 | Yoshitomi Pharmaceut Ind Ltd | 酸不安定物質の内服用新規医薬製剤 |
| JPH0222225A (ja) * | 1988-07-11 | 1990-01-25 | Eisai Co Ltd | 胃酸分泌抑制剤含有固型製剤 |
| JPH02138213A (ja) * | 1988-08-18 | 1990-05-28 | Takeda Chem Ind Ltd | 注射剤 |
| JPH03163018A (ja) * | 1990-11-20 | 1991-07-15 | Takeda Chem Ind Ltd | 医薬固形組成物用安定化剤および安定化方法 |
| JP2002114779A (ja) * | 2000-08-04 | 2002-04-16 | Takeda Chem Ind Ltd | ベンズイミダゾール化合物の塩およびその用途 |
| JP2004155773A (ja) * | 2002-10-16 | 2004-06-03 | Takeda Chem Ind Ltd | 安定な固形製剤 |
| US6780882B2 (en) | 1996-01-04 | 2004-08-24 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| JP2006514049A (ja) * | 2002-12-20 | 2006-04-27 | タツプ・フアーマシユーテイカル・プロダクツ・インコーポレイテツド | プロトンポンプ阻害剤、nsaid及び緩衝剤を含む剤形 |
| JP2006515353A (ja) * | 2003-01-15 | 2006-05-25 | シプラ・リミテッド | 製薬的方法、及び該方法により製造された化合物 |
| JP2006528181A (ja) * | 2003-07-18 | 2006-12-14 | サンタラス インコーポレイティッド | 酸分泌を阻害するために有用な薬学的製剤ならびにそれらを作製および使用する方法 |
| EP1736144A2 (fr) | 1998-05-18 | 2006-12-27 | Takeda Pharmaceutical Company Limited | Comprimé à désintégration orale |
| US7220762B1 (en) | 1999-10-20 | 2007-05-22 | Eisai R&D Management Co., Ltd. | Methods for stabilizing benzimidazole compounds |
| WO2007074909A1 (fr) | 2005-12-28 | 2007-07-05 | Takeda Pharmaceutical Company Limited | Preparation solide a liberation controlee |
| WO2007074856A1 (fr) | 2005-12-28 | 2007-07-05 | Takeda Pharmaceutical Company Limited | Procede de production de preparation solide se desintegrant dans la cavite orale |
| WO2007074910A1 (fr) * | 2005-12-28 | 2007-07-05 | Takeda Pharmaceutical Company Limited | Preparation solide a liberation controlee |
| JP2008530175A (ja) * | 2005-02-16 | 2008-08-07 | ソルヴェイ(ソシエテ アノニム) | 生物学的活性物質と、炭酸カルシウム含有賦形剤とを含む錠剤 |
| WO2008111278A1 (fr) * | 2007-03-12 | 2008-09-18 | Tomita Pharmaceutical Co., Ltd. | Vecteur pharmaceutique et produit pharmaceutique |
| JP2008255088A (ja) * | 2007-03-12 | 2008-10-23 | Tomita Pharmaceutical Co Ltd | 製剤用球形核粒子 |
| WO2009069280A1 (fr) * | 2007-11-27 | 2009-06-04 | Ohara Pharmaceutical Co., Ltd. | Procédé de production d'une substance granulée |
| JP2010180225A (ja) * | 2002-10-16 | 2010-08-19 | Takeda Chem Ind Ltd | 安定な固形製剤 |
| EP2258351A2 (fr) | 2001-10-17 | 2010-12-08 | Takeda Pharmaceutical Company Limited | Granules contenant lansoprazol en grande quantité |
| EP2277510A2 (fr) | 2002-10-16 | 2011-01-26 | Takeda Pharmaceutical Company Limited | Préparation à libération contrôlée. |
| US8124780B2 (en) | 2005-04-15 | 2012-02-28 | Eisai R&D Management Co., Ltd. | Benzimidazole compound |
| WO2012091153A2 (fr) | 2010-12-27 | 2012-07-05 | Takeda Pharmaceutical Company Limited | Comprimé orodispersible |
| USRE45198E1 (en) | 1996-01-04 | 2014-10-14 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
| US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US9040564B2 (en) | 2005-04-28 | 2015-05-26 | Eisai R&D Management Co., Ltd. | Stabilized composition |
| US9241910B2 (en) | 2008-03-11 | 2016-01-26 | Takeda Pharmaceutical Company Limited | Orally-disintegrating solid preparation |
| WO2018229744A1 (fr) | 2017-06-12 | 2018-12-20 | Glytech Llc. | Traitement de la dépression avec des antagonistes du nmda et de la d2/5ht2a ou des antagonistes de la 5ht2a sélectifs |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58135881A (ja) * | 1981-11-05 | 1983-08-12 | ビク−グルデン・ロムベルク・ヘミツシエ・フアブリク・ゲゼルシヤフト・ミト・ベシユレンクテル・ハフツング | 置換ベンズイミダゾ−ル類、その製造方法と利用、およびこれを含む医薬 |
| JPS59167587A (ja) * | 1983-03-04 | 1984-09-21 | アクチエボラゲツト・ヘツスレ | オメプラゾ−ル化合物 |
-
1987
- 1987-02-12 JP JP2999787A patent/JPS62277322A/ja active Granted
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58135881A (ja) * | 1981-11-05 | 1983-08-12 | ビク−グルデン・ロムベルク・ヘミツシエ・フアブリク・ゲゼルシヤフト・ミト・ベシユレンクテル・ハフツング | 置換ベンズイミダゾ−ル類、その製造方法と利用、およびこれを含む医薬 |
| JPS59167587A (ja) * | 1983-03-04 | 1984-09-21 | アクチエボラゲツト・ヘツスレ | オメプラゾ−ル化合物 |
Cited By (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62258316A (ja) * | 1986-04-30 | 1987-11-10 | Yoshitomi Pharmaceut Ind Ltd | 酸不安定物質の内服用新規医薬製剤 |
| JPS62258320A (ja) * | 1986-04-30 | 1987-11-10 | Yoshitomi Pharmaceut Ind Ltd | 内服用新規医薬製剤 |
| JPH0222225A (ja) * | 1988-07-11 | 1990-01-25 | Eisai Co Ltd | 胃酸分泌抑制剤含有固型製剤 |
| JPH02138213A (ja) * | 1988-08-18 | 1990-05-28 | Takeda Chem Ind Ltd | 注射剤 |
| JPH03163018A (ja) * | 1990-11-20 | 1991-07-15 | Takeda Chem Ind Ltd | 医薬固形組成物用安定化剤および安定化方法 |
| USRE45198E1 (en) | 1996-01-04 | 2014-10-14 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
| US6780882B2 (en) | 1996-01-04 | 2004-08-24 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| EP2263660A2 (fr) | 1998-05-18 | 2010-12-22 | Takeda Pharmaceutical Company Limited | Comprimé se désintégrant dans la bouche |
| EP1736144A2 (fr) | 1998-05-18 | 2006-12-27 | Takeda Pharmaceutical Company Limited | Comprimé à désintégration orale |
| US7220762B1 (en) | 1999-10-20 | 2007-05-22 | Eisai R&D Management Co., Ltd. | Methods for stabilizing benzimidazole compounds |
| JP2002114779A (ja) * | 2000-08-04 | 2002-04-16 | Takeda Chem Ind Ltd | ベンズイミダゾール化合物の塩およびその用途 |
| EP2258351A2 (fr) | 2001-10-17 | 2010-12-08 | Takeda Pharmaceutical Company Limited | Granules contenant lansoprazol en grande quantité |
| JP2010180225A (ja) * | 2002-10-16 | 2010-08-19 | Takeda Chem Ind Ltd | 安定な固形製剤 |
| EP2596792A1 (fr) | 2002-10-16 | 2013-05-29 | Takeda Pharmaceutical Company Limited | Préparations solides stables |
| JP2004155773A (ja) * | 2002-10-16 | 2004-06-03 | Takeda Chem Ind Ltd | 安定な固形製剤 |
| US8697094B2 (en) | 2002-10-16 | 2014-04-15 | Takeda Pharmaceutical Company Limited | Stable solid preparations |
| US8697097B2 (en) | 2002-10-16 | 2014-04-15 | Takeda Pharmaceutical Company Limited | Stable solid preparations |
| JP2013151525A (ja) * | 2002-10-16 | 2013-08-08 | Takeda Chem Ind Ltd | 安定な固形製剤 |
| EP2596791A1 (fr) | 2002-10-16 | 2013-05-29 | Takeda Pharmaceutical Company Limited | Préparations solides stables |
| JP2015145405A (ja) * | 2002-10-16 | 2015-08-13 | 武田薬品工業株式会社 | 安定な固形製剤 |
| US9265730B2 (en) | 2002-10-16 | 2016-02-23 | Takeda Pharmaceutical Company Limited | Stable solid preparations |
| EP2283827A1 (fr) | 2002-10-16 | 2011-02-16 | Takeda Pharmaceutical Company Limited | Préparation à libération contrôlée |
| EP2277510A2 (fr) | 2002-10-16 | 2011-01-26 | Takeda Pharmaceutical Company Limited | Préparation à libération contrôlée. |
| JP2006514049A (ja) * | 2002-12-20 | 2006-04-27 | タツプ・フアーマシユーテイカル・プロダクツ・インコーポレイテツド | プロトンポンプ阻害剤、nsaid及び緩衝剤を含む剤形 |
| JP2012107021A (ja) * | 2002-12-20 | 2012-06-07 | Takeda Pharmaceuticals Usa Inc | プロトンポンプ阻害剤、nsaid及び緩衝剤を含む剤形 |
| JP2006515353A (ja) * | 2003-01-15 | 2006-05-25 | シプラ・リミテッド | 製薬的方法、及び該方法により製造された化合物 |
| JP2006528181A (ja) * | 2003-07-18 | 2006-12-14 | サンタラス インコーポレイティッド | 酸分泌を阻害するために有用な薬学的製剤ならびにそれらを作製および使用する方法 |
| US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| JP2008530175A (ja) * | 2005-02-16 | 2008-08-07 | ソルヴェイ(ソシエテ アノニム) | 生物学的活性物質と、炭酸カルシウム含有賦形剤とを含む錠剤 |
| US8124780B2 (en) | 2005-04-15 | 2012-02-28 | Eisai R&D Management Co., Ltd. | Benzimidazole compound |
| US9040564B2 (en) | 2005-04-28 | 2015-05-26 | Eisai R&D Management Co., Ltd. | Stabilized composition |
| WO2007074909A1 (fr) | 2005-12-28 | 2007-07-05 | Takeda Pharmaceutical Company Limited | Preparation solide a liberation controlee |
| WO2007074910A1 (fr) * | 2005-12-28 | 2007-07-05 | Takeda Pharmaceutical Company Limited | Preparation solide a liberation controlee |
| WO2007074856A1 (fr) | 2005-12-28 | 2007-07-05 | Takeda Pharmaceutical Company Limited | Procede de production de preparation solide se desintegrant dans la cavite orale |
| JPWO2007074910A1 (ja) * | 2005-12-28 | 2009-06-04 | 武田薬品工業株式会社 | 放出制御固形製剤 |
| JPWO2007074909A1 (ja) * | 2005-12-28 | 2009-06-04 | 武田薬品工業株式会社 | 放出制御固形製剤 |
| WO2008111278A1 (fr) * | 2007-03-12 | 2008-09-18 | Tomita Pharmaceutical Co., Ltd. | Vecteur pharmaceutique et produit pharmaceutique |
| JP2008255088A (ja) * | 2007-03-12 | 2008-10-23 | Tomita Pharmaceutical Co Ltd | 製剤用球形核粒子 |
| WO2009069280A1 (fr) * | 2007-11-27 | 2009-06-04 | Ohara Pharmaceutical Co., Ltd. | Procédé de production d'une substance granulée |
| JPWO2009069280A1 (ja) * | 2007-11-27 | 2011-04-07 | 大原薬品工業株式会社 | 造粒物の製造法 |
| US9241910B2 (en) | 2008-03-11 | 2016-01-26 | Takeda Pharmaceutical Company Limited | Orally-disintegrating solid preparation |
| WO2012091153A2 (fr) | 2010-12-27 | 2012-07-05 | Takeda Pharmaceutical Company Limited | Comprimé orodispersible |
| WO2018229744A1 (fr) | 2017-06-12 | 2018-12-20 | Glytech Llc. | Traitement de la dépression avec des antagonistes du nmda et de la d2/5ht2a ou des antagonistes de la 5ht2a sélectifs |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0338247B2 (fr) | 1991-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS62277322A (ja) | 安定化された腸溶性抗潰瘍固形組成物 | |
| DE3780045T2 (de) | Verwendung von basischen anorganischen magnesium- oder calciumsalzen zur stabilisierung von benzimidazolderivaten. | |
| US5879708A (en) | Stabilized pharmaceutical composition | |
| US6749864B2 (en) | Stabilized pharmaceutical composition | |
| HK1002021B (en) | Stabilized pharmaceutical composition and its production | |
| JP4834553B2 (ja) | 医薬組成物 | |
| KR930010495B1 (ko) | 피리딘 유도체의 제조방법 | |
| DE3530046C2 (de) | Äthylendiaminmonoamid-Derivate | |
| JP2762998B2 (ja) | 医薬固形組成物用安定化剤および安定化方法 | |
| JPH03163018A (ja) | 医薬固形組成物用安定化剤および安定化方法 | |
| JPS63502658A (ja) | 新規な物質の組成 | |
| JPH10273440A (ja) | ピリダジノン化合物類の経口製剤 | |
| CA1338377C (fr) | Composition pharmaceutique stabilisee et sa preparation | |
| KR950007211B1 (ko) | 안전화된 약제 조성물 및 항궤양 약제 조성물의 안정화 방법 | |
| IE904248A1 (en) | Therapeutically active fluoro substituted benzimidazoles,¹processes for their preparation as well as their use | |
| JPH05112559A (ja) | 4−アミノ−5−ピリミジンカルボン酸誘導体 | |
| JPH08311041A (ja) | 複素環化合物およびその剤 | |
| JPH072636B2 (ja) | 胃腸の細胞保護剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |